Codexis, Inc.

NasdaqGS:CDXS Stock Report

Market Cap: US$151.7m

Codexis Management

Management criteria checks 1/4

Codexis' CEO is Alison Moore, appointed in Oct 2025, has a tenure of less than a year. total yearly compensation is $1.44M, comprised of 8% salary and 92% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $183.32K. The average tenure of the management team and the board of directors is 0.8 years and 2.4 years respectively.

Key information

Alison Moore

Chief executive officer

US$1.4m

Total compensation

CEO salary percentage7.99%
CEO tenureless than a year
CEO ownership0.1%
Management average tenureless than a year
Board average tenure2.4yrs

Recent management updates

Recent updates

Codexis Weighs ECO Scale As Cash Runway Tightens

Sep 16

What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S

Jul 03
What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S

Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 17
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
User avatar

ECO Synthesis Launch In 2025 Will Unlock Pharma Contracts

Transitioning to commercial execution with ECO Synthesis and partnerships enhances revenue growth by securing new contracts and expanding into pharma and biotech segments.

Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Mar 28
Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Estimating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

Jan 06
Estimating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

Is Codexis (NASDAQ:CDXS) Using Debt In A Risky Way?

Dec 10
Is Codexis (NASDAQ:CDXS) Using Debt In A Risky Way?

Codexis, Inc.'s (NASDAQ:CDXS) 29% Jump Shows Its Popularity With Investors

Nov 07
Codexis, Inc.'s (NASDAQ:CDXS) 29% Jump Shows Its Popularity With Investors

After Leaping 26% Codexis, Inc. (NASDAQ:CDXS) Shares Are Not Flying Under The Radar

Jul 26
After Leaping 26% Codexis, Inc. (NASDAQ:CDXS) Shares Are Not Flying Under The Radar

Is Codexis (NASDAQ:CDXS) Weighed On By Its Debt Load?

Jul 12
Is Codexis (NASDAQ:CDXS) Weighed On By Its Debt Load?

Investors Appear Satisfied With Codexis, Inc.'s (NASDAQ:CDXS) Prospects

May 29
Investors Appear Satisfied With Codexis, Inc.'s (NASDAQ:CDXS) Prospects

Codexis, Inc.'s (NASDAQ:CDXS) Shares Leap 56% Yet They're Still Not Telling The Full Story

Dec 20
Codexis, Inc.'s (NASDAQ:CDXS) Shares Leap 56% Yet They're Still Not Telling The Full Story

What Does Codexis, Inc.'s (NASDAQ:CDXS) Share Price Indicate?

Dec 19
What Does Codexis, Inc.'s (NASDAQ:CDXS) Share Price Indicate?

Is Codexis (NASDAQ:CDXS) In A Good Position To Deliver On Growth Plans?

Nov 15
Is Codexis (NASDAQ:CDXS) In A Good Position To Deliver On Growth Plans?

Lacklustre Performance Is Driving Codexis, Inc.'s (NASDAQ:CDXS) Low P/S

Jun 28
Lacklustre Performance Is Driving Codexis, Inc.'s (NASDAQ:CDXS) Low P/S

Calculating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

Jun 07
Calculating The Intrinsic Value Of Codexis, Inc. (NASDAQ:CDXS)

At US$3.41, Is It Time To Put Codexis, Inc. (NASDAQ:CDXS) On Your Watch List?

May 09
At US$3.41, Is It Time To Put Codexis, Inc. (NASDAQ:CDXS) On Your Watch List?

Analysts Just Made A Major Revision To Their Codexis, Inc. (NASDAQ:CDXS) Revenue Forecasts

Feb 27
Analysts Just Made A Major Revision To Their Codexis, Inc. (NASDAQ:CDXS) Revenue Forecasts

We're Not Worried About Codexis' (NASDAQ:CDXS) Cash Burn

Feb 25
We're Not Worried About Codexis' (NASDAQ:CDXS) Cash Burn

CEO Compensation Analysis

How has Alison Moore's remuneration changed compared to Codexis's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$64m

Jun 30 2025n/an/a

-US$65m

Mar 31 2025n/an/a

-US$74m

Dec 31 2024US$1mUS$115k

-US$65m

Sep 30 2024n/an/a

-US$62m

Jun 30 2024n/an/a

-US$76m

Mar 31 2024n/an/a

-US$65m

Dec 31 2023US$190kn/a

-US$76m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$57m

Mar 31 2023n/an/a

-US$48m

Dec 31 2022US$190kn/a

-US$34m

Sep 30 2022n/an/a

-US$31m

Jun 30 2022n/an/a

-US$19m

Mar 31 2022n/an/a

-US$21m

Dec 31 2021US$180kn/a

-US$21m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020US$243kn/a

-US$24m

Compensation vs Market: Alison's total compensation ($USD1.44M) is about average for companies of similar size in the US market ($USD1.45M).

Compensation vs Earnings: Alison's compensation has increased whilst the company is unprofitable.

CEO

Alison Moore (58 yo)

less than a year
Tenure
US$1,444,468
Compensation

Dr. Alison Moore, Ph D., is Independent Director of Artiva Biotherapeutics, Inc. from October 2024. Dr. Moore served as Independent Director at Codexis, Inc since June 16, 2020 and served as its Chief Tech...

Leadership Team

NamePositionTenureCompensationOwnership
Alison Moore
Presidentless than a yearUS$1.44m0.12%
$ 183.3k
Georgia Erbez
CFO & Chief Business Officer1.2yrsUS$1.27m0.041%
$ 62.7k
Byron Dorgan
Consultantless than a yearUS$203.64k0.21%
$ 325.0k
Stefan Lutz
Chief Scientific Officerless than a yearno data0.10%
$ 151.5k
Carrie McKim
Director of Investor Relationsno datano datano data
Britton Jimenez
Senior Vice President of Sales & Marketingno datano datano data
Karen Frechou-Armijo
Senior VP & Head of Human Resources4.1yrsno datano data
John Schiffhauer
Senior Vice President of Intellectual Property1.2yrsno datano data
0.8yrs
Average Tenure
58yo
Average Age

Experienced Management: CDXS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Alison Moore
Presidentless than a yearUS$1.44m0.12%
$ 183.3k
H. Parker
Independent Director3yrsUS$187.28k0.11%
$ 172.4k
John M. Maraganore
Member of Strategic Advisory Board1.8yrsno datano data
Stephen Dilly
Chairman5.5yrsUS$3.47m0.56%
$ 848.7k
David Smith
Lead Independent Director9.8yrsUS$214.84k0.17%
$ 257.5k
Carole Cobb
Member of Strategic Advisory Board1.7yrsno datano data
Dennis Wolf
Independent Director18yrsUS$190.00k0.11%
$ 164.6k
Rahul Singhvi
Independent Director3.2yrsUS$205.00k0.11%
$ 161.4k
James Lalonde
Member of Strategic Advisory Board1.8yrsUS$1.02mno data
Masad Damha
Member of Strategic Advisory Board1.8yrsno datano data
Raymond De Vre
Director1.1yrsUS$207.47k0.016%
$ 24.4k
Esther Martinborough
Independent Director4.8yrsUS$175.00k0.097%
$ 147.9k
2.4yrs
Average Tenure
64yo
Average Age

Experienced Board: CDXS's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 20:54
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Codexis, Inc. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
J. HorwitzBaird
Vishal ShahBarclays
Robert WassermanBenchmark Company